TreeWAS – Variant ID: rs187497509

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E78.0 Pure hypercholesterolaemia	0.000	0.992	0.008
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.000	0.994	0.006
I25.2 Old myocardial infarction	0.000	0.995	0.005
E78.5 Hyperlipidaemia, unspecified	0.000	0.995	0.005
I25 Chronic ischaemic heart disease	0.000	0.995	0.005
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.996	0.004
E78.8 Other disorders of lipoprotein metabolism	0.000	0.996	0.004
E78.6 Lipoprotein deficiency	0.000	0.996	0.004
E78.4 Other hyperlipidaemia	0.000	0.996	0.004
E78.3 Hyperchylomicronaemia	0.000	0.996	0.004
E78.2 Mixed hyperlipidaemia	0.000	0.996	0.004
E78.1 Pure hyperglyceridaemia	0.000	0.996	0.004
I25.1 Atherosclerotic heart disease	0.000	0.996	0.004
I25.8 Other forms of chronic ischaemic heart disease	0.000	0.996	0.004
I20-I25 Ischaemic heart diseases	0.000	0.996	0.004
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.996	0.004
I25.6 Silent myocardial ischaemia	0.000	0.996	0.003
I25.5 Ischaemic cardiomyopathy	0.000	0.996	0.003
I25.4 Coronary artery aneurysm	0.000	0.996	0.003
I25.3 Aneurysm of heart	0.000	0.996	0.003
I25.0 Atherosclerotic cardiovascular disease, so described	0.000	0.996	0.003
I20 Angina pectoris	0.000	0.996	0.004
E70-E90 Metabolic disorders	0.000	0.996	0.003
I20.0 Unstable angina	0.000	0.997	0.003
Z86.7 Personal history of diseases of the circulatory system	0.000	0.997	0.003
I21 Acute myocardial infarction	0.000	0.997	0.003
I21.9 Acute myocardial infarction, unspecified	0.000	0.997	0.003
I24 Other acute ischaemic heart diseases	0.000	0.997	0.003
I23 Certain current complications following acute myocardial infarction	0.000	0.997	0.003
I22 Subsequent myocardial infarction	0.000	0.997	0.003
E86 Volume depletion	0.000	0.997	0.003
I20.8 Other forms of angina pectoris	0.000	0.997	0.003
I20.1 Angina pectoris with documented spasm	0.000	0.997	0.003
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.997	0.003
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.000	0.997	0.003
E88 Other metabolic disorders	0.000	0.997	0.003
E85 Amyloidosis	0.000	0.997	0.003
E84 Cystic fibrosis	0.000	0.997	0.003
E83 Disorders of mineral metabolism	0.000	0.997	0.003
E80 Disorders of porphyrin and bilirubin metabolism	0.000	0.997	0.003
E79 Disorders of purine and pyrimidine metabolism	0.000	0.997	0.003
E77 Disorders of glycoprotein metabolism	0.000	0.997	0.003
E76 Disorders of glycosaminoglycan metabolism	0.000	0.997	0.003
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.000	0.997	0.003
E74 Other disorders of carbohydrate metabolism	0.000	0.997	0.003
E73 Lactose intolerance	0.000	0.997	0.003
E72 Other disorders of amino-acid metabolism	0.000	0.997	0.003
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.000	0.997	0.003
E70 Disorders of aromatic amino-acid metabolism	0.000	0.997	0.003
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.000	0.997	0.003
I20.9 Angina pectoris, unspecified	0.000	0.997	0.003
I21.X Presumed acute myicardial infaction (unconfirmed)	0.000	0.997	0.003
I21.4 Acute subendocardial myocardial infarction	0.000	0.997	0.003
I21.3 Acute transmural myocardial infarction of unspecified site	0.000	0.997	0.003
I21.2 Acute transmural myocardial infarction of other sites	0.000	0.997	0.003
I21.0 Acute transmural myocardial infarction of anterior wall	0.000	0.997	0.002
E87 Other disorders of fluid, electrolyte and acid-base balance	0.000	0.997	0.002
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.998	0.002
I22.8 Subsequent myocardial infarction of other sites	0.000	0.998	0.002
I22.1 Subsequent myocardial infarction of inferior wall	0.000	0.998	0.002
I22.0 Subsequent myocardial infarction of anterior wall	0.000	0.998	0.002
I23.8 Other current complications following acute myocardial infarction	0.000	0.998	0.002
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction	0.000	0.998	0.002
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction	0.000	0.998	0.002
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction	0.000	0.998	0.002
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction	0.000	0.998	0.002
I23.2 Ventricular septal defect as current complication following acute myocardial infarction	0.000	0.998	0.002
I23.1 Atrial septal defect as current complication following acute myocardial infarction	0.000	0.998	0.002
I23.0 Haemopericardium as current complication following acute myocardial infarction	0.000	0.998	0.002
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.998	0.002
I24.8 Other forms of acute ischaemic heart disease	0.000	0.998	0.002
I24.1 Dressler's syndrome	0.000	0.998	0.002
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.998	0.002
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.000	0.998	0.002
E70.8 Other disorders of aromatic amino-acid metabolism	0.000	0.998	0.002
E70.3 Albinism	0.000	0.998	0.002
E70.2 Disorders of tyrosine metabolism	0.000	0.998	0.002
E70.1 Other hyperphenylalaninaemias	0.000	0.998	0.002
E70.0 Classical phenylketonuria	0.000	0.998	0.002
E71.3 Disorders of fatty-acid metabolism	0.000	0.998	0.002
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.000	0.998	0.002
E71.1 Other disorders of branched-chain amino-acid metabolism	0.000	0.998	0.002
E71.0 Maple-syrup-urine disease	0.000	0.998	0.002
E72.9 Disorder of amino-acid metabolism, unspecified	0.000	0.998	0.002
E72.8 Other specified disorders of amino-acid metabolism	0.000	0.998	0.002
E72.5 Disorders of glycine metabolism	0.000	0.998	0.002
E72.4 Disorders of ornithine metabolism	0.000	0.998	0.002
E72.3 Disorders of lysine and hydroxylysine metabolism	0.000	0.998	0.002
E72.2 Disorders of urea cycle metabolism	0.000	0.998	0.002
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.000	0.998	0.002
E72.0 Disorders of amino-acid transport	0.000	0.998	0.002
E73.9 Lactose intolerance, unspecified	0.000	0.998	0.002
E73.8 Other lactose intolerance	0.000	0.998	0.002
E73.1 Secondary lactase deficiency	0.000	0.998	0.002
E73.0 Congenital lactase deficiency	0.000	0.998	0.002
E74.9 Disorder of carbohydrate metabolism, unspecified	0.000	0.998	0.002
E74.8 Other specified disorders of carbohydrate metabolism	0.000	0.998	0.002
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.000	0.998	0.002
E74.3 Other disorders of intestinal carbohydrate absorption	0.000	0.998	0.002
E74.2 Disorders of galactose metabolism	0.000	0.998	0.002
E74.1 Disorders of fructose metabolism	0.000	0.998	0.002
E74.0 Glycogen storage disease	0.000	0.998	0.002
E75.6 Lipid storage disorder, unspecified	0.000	0.998	0.002
E75.5 Other lipid storage disorders	0.000	0.998	0.002
E75.4 Neuronal ceroid lipofuscinosis	0.000	0.998	0.002
E75.3 Sphingolipidosis, unspecified	0.000	0.998	0.002
E75.2 Other sphingolipidosis	0.000	0.998	0.002
E75.1 Other gangliosidosis	0.000	0.998	0.002
E75.0 GM2 gangliosidosis	0.000	0.998	0.002
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.000	0.998	0.002
E76.8 Other disorders of glucosaminoglycan metabolism	0.000	0.998	0.002
E76.3 Mucopolysaccharidosis, unspecified	0.000	0.998	0.002
E76.2 Other mucopolysaccharidoses	0.000	0.998	0.002
E76.1 Mucopolysaccharidosis, type II	0.000	0.998	0.002
E76.0 Mucopolysaccharidosis, type I	0.000	0.998	0.002
E77.9 Disorder of glycoprotein metabolism, unspecified	0.000	0.998	0.002
E77.8 Other disorders of glycoprotein metabolism	0.000	0.998	0.002
E77.1 Defects in glycoprotein degradation	0.000	0.998	0.002
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.000	0.998	0.002
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.000	0.998	0.002
E79.8 Other disorders of purine and pyrimidine metabolism	0.000	0.998	0.002
E79.1 Lesch-Nyhan syndrome	0.000	0.998	0.002
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.000	0.998	0.002
E80.7 Disorder of bilirubin metabolism, unspecified	0.000	0.998	0.002
E80.6 Other disorders of bilirubin metabolism	0.000	0.998	0.002
E80.5 Crigler-Najjar syndrome	0.000	0.998	0.002
E80.4 Gilbert's syndrome	0.000	0.998	0.002
E80.3 Defects of catalase and peroxydase	0.000	0.998	0.002
E80.2 Other porphyria	0.000	0.998	0.002
E80.1 Porphyria cutanea tarda	0.000	0.998	0.002
E80.0 Hereditary erythropoietic porphyria	0.000	0.998	0.002
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.998	0.002
E83.8 Other disorders of mineral metabolism	0.000	0.998	0.002
E83.5 Disorders of calcium metabolism	0.000	0.998	0.002
E83.4 Disorders of magnesium metabolism	0.000	0.998	0.002
E83.3 Disorders of phosphorus metabolism	0.000	0.998	0.002
E83.2 Disorders of zinc metabolism	0.000	0.998	0.002
E83.1 Disorders of iron metabolism	0.000	0.998	0.002
E83.0 Disorders of copper metabolism	0.000	0.998	0.002
E84.9 Cystic fibrosis, unspecified	0.000	0.998	0.002
E84.8 Cystic fibrosis with other manifestations	0.000	0.998	0.002
E84.1 Cystic fibrosis with intestinal manifestations	0.000	0.998	0.002
E84.0 Cystic fibrosis with pulmonary manifestations	0.000	0.998	0.002
E85.9 Amyloidosis, unspecified	0.000	0.998	0.002
E85.8 Other amyloidosis	0.000	0.998	0.002
E85.4 Organ-limited amyloidosis	0.000	0.998	0.002
E85.3 Secondary systemic amyloidosis	0.000	0.998	0.002
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.998	0.002
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.998	0.002
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.998	0.002
E88.9 Metabolic disorder, unspecified	0.000	0.998	0.002
E88.8 Other specified metabolic disorders	0.000	0.998	0.002
E88.3 Tumour lysis syndrome	0.000	0.998	0.002
E88.2 Lipomatosis, not elsewhere classified	0.000	0.998	0.002
E88.1 Lipodystrophy, not elsewhere classified	0.000	0.998	0.002
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.000	0.998	0.002
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.000	0.998	0.002
E89.8 Other postprocedural endocrine and metabolic disorders	0.000	0.998	0.002
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.000	0.998	0.002
E89.5 Postprocedural testicular hypofunction	0.000	0.998	0.002
E89.4 Postprocedural ovarian failure	0.000	0.998	0.002
E89.3 Postprocedural hypopituitarism	0.000	0.998	0.002
E89.2 Postprocedural hypoparathyroidism	0.000	0.998	0.002
E89.1 Postprocedural hypoinsulinaemia	0.000	0.998	0.002
E89.0 Postprocedural hypothyroidism	0.000	0.998	0.002
E11.9 Without complications	0.000	0.998	0.002
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.000	0.998	0.002
E87.7 Fluid overload	0.000	0.998	0.002
E87.6 Hypokalaemia	0.000	0.998	0.002
E87.5 Hyperkalaemia	0.000	0.998	0.002
E87.4 Mixed disorder of acid-base balance	0.000	0.998	0.002
E87.3 Alkalosis	0.000	0.998	0.002
E87.2 Acidosis	0.000	0.998	0.002
E87.0 Hyperosmolality and hypernatraemia	0.000	0.998	0.002
I10 Essential (primary) hypertension	0.000	0.998	0.002
E11 Non-insulin-dependent diabetes mellitus	0.000	0.998	0.002
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.998	0.002
E10-E14 Diabetes mellitus	0.000	0.998	0.002
E87.1 Hypo-osmolality and hyponatraemia	0.000	0.998	0.002
I10-I15 Hypertensive diseases	0.000	0.998	0.002
E00-E07 Disorders of thyroid gland	0.000	0.998	0.002
E11.8 With unspecified complications	0.000	0.998	0.002
E11.7 With multiple complications	0.000	0.998	0.002
E11.6 With other specified complications	0.000	0.998	0.002
E11.5 With peripheral circulatory complications	0.000	0.998	0.002
E11.4 With neurological complications	0.000	0.998	0.002
E11.3 With ophthalmic complications	0.000	0.998	0.002
E11.2 With renal complications	0.000	0.998	0.002
E11.1 With ketoacidosis	0.000	0.998	0.002
E11.0 With coma	0.000	0.998	0.002
E50-E64 Other nutritional deficiencies	0.000	0.998	0.002
E40-E46 Malnutrition	0.000	0.998	0.002
E20-E35 Disorders of other endocrine glands	0.000	0.998	0.002
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.998	0.002
E13 Other specified diabetes mellitus	0.000	0.998	0.002
E12 Malnutrition-related diabetes mellitus	0.000	0.998	0.002
E10 Insulin-dependent diabetes mellitus	0.000	0.998	0.002
Chapter IX Diseases of the circulatory system	0.000	0.998	0.002
Z37.0 Single live birth	0.002	0.998	0.000
E03 Other hypothyroidism	0.000	0.998	0.002
E14 Unspecified diabetes mellitus	0.000	0.998	0.001
D12.2 Ascending colon	0.002	0.998	0.000
I15 Secondary hypertension	0.000	0.998	0.001
I13 Hypertensive heart and renal disease	0.000	0.998	0.001
I12 Hypertensive renal disease	0.000	0.998	0.001
I11 Hypertensive heart disease	0.000	0.998	0.001
Z30.2 Sterilisation	0.001	0.998	0.000
E07 Other disorders of thyroid	0.000	0.998	0.001
E06 Thyroiditis	0.000	0.998	0.001
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.998	0.001
E04 Other non-toxic goitre	0.000	0.998	0.001
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.998	0.001
E00 Congenital iodine-deficiency syndrome	0.000	0.998	0.001
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.998	0.001
E65-E68 Obesity and other hyperalimentation	0.000	0.998	0.001
E16 Other disorders of pancreatic internal secretion	0.000	0.998	0.001
E15 Nondiabetic hypoglycaemic coma	0.000	0.998	0.001
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.998	0.001
E34 Other endocrine disorders	0.000	0.998	0.001
E32 Diseases of thymus	0.000	0.998	0.001
E31 Polyglandular dysfunction	0.000	0.998	0.001
E30 Disorders of puberty, not elsewhere classified	0.000	0.998	0.001
E29 Testicular dysfunction	0.000	0.998	0.001
E28 Ovarian dysfunction	0.000	0.998	0.001
E27 Other disorders of adrenal gland	0.000	0.998	0.001
E26 Hyperaldosteronism	0.000	0.998	0.001
E25 Adrenogenital disorders	0.000	0.998	0.001
E24 Cushing's syndrome	0.000	0.998	0.001
E23 Hypofunction and other disorders of pituitary gland	0.000	0.998	0.001
E22 Hyperfunction of pituitary gland	0.000	0.998	0.001
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.998	0.001
E20 Hypoparathyroidism	0.000	0.998	0.001
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.998	0.001
E46 Unspecified protein-energy malnutrition	0.000	0.998	0.001
E45 Retarded development following protein-energy malnutrition	0.000	0.998	0.001
E43 Unspecified severe protein-energy malnutrition	0.000	0.998	0.001
E42 Marasmic kwashiorkor	0.000	0.998	0.001
E41 Nutritional marasmus	0.000	0.998	0.001
E40 Kwashiorkor	0.000	0.998	0.001
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.998	0.001
E63 Other nutritional deficiencies	0.000	0.998	0.001
E61 Deficiency of other nutrient elements	0.000	0.998	0.001
E56 Other vitamin deficiencies	0.000	0.998	0.001
E55 Vitamin D deficiency	0.000	0.998	0.001
E53 Deficiency of other B group vitamins	0.000	0.998	0.001
E51 Thiamine deficiency	0.000	0.998	0.001
E50 Vitamin A deficiency	0.000	0.998	0.001
E60 Dietary zinc deficiency	0.000	0.998	0.001
E59 Dietary selenium deficiency	0.000	0.998	0.001
E58 Dietary calcium deficiency	0.000	0.998	0.001
E54 Ascorbic acid deficiency	0.000	0.998	0.001
E52 Niacin deficiency [pellagra]	0.000	0.998	0.001
E03.9 Hypothyroidism, unspecified	0.000	0.998	0.001
Z86 Personal history of certain other diseases	0.000	0.998	0.002
E10.9 Without complications	0.000	0.998	0.001
E10.8 With unspecified complications	0.000	0.998	0.001
E10.7 With multiple complications	0.000	0.998	0.001
E10.6 With other specified complications	0.000	0.998	0.001
E10.5 With peripheral circulatory complications	0.000	0.998	0.001
E10.4 With neurological complications	0.000	0.998	0.001
E10.3 With ophthalmic complications	0.000	0.998	0.001
E10.2 With renal complications	0.000	0.998	0.001
E10.1 With ketoacidosis	0.000	0.998	0.001
E10.0 With coma	0.000	0.998	0.001
E12.9 Without complications	0.000	0.998	0.001
E12.8 With unspecified complications	0.000	0.998	0.001
E12.7 With multiple complications	0.000	0.998	0.001
E12.6 With other specified complications	0.000	0.998	0.001
E12.5 With peripheral circulatory complications	0.000	0.998	0.001
E12.4 With neurological complications	0.000	0.998	0.001
E12.3 With ophthalmic complications	0.000	0.998	0.001
E12.2 With renal complications	0.000	0.998	0.001
E12.1 With ketoacidosis	0.000	0.998	0.001
E12.0 With coma	0.000	0.998	0.001
E13.9 Without complications	0.000	0.998	0.001
E13.8 With unspecified complications	0.000	0.998	0.001
E13.7 With multiple complications	0.000	0.998	0.001
E13.6 With other specified complications	0.000	0.998	0.001
E13.5 With peripheral circulatory complications	0.000	0.998	0.001
E13.4 With neurological complications	0.000	0.998	0.001
E13.3 With ophthalmic complications	0.000	0.998	0.001
E13.2 With renal complications	0.000	0.998	0.001
E13.1 With ketoacidosis	0.000	0.998	0.001
E13.0 With coma	0.000	0.998	0.001
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.998	0.001
M54.56 Low back pain (Lumbar region)	0.001	0.998	0.000
I05-I09 Chronic rheumatic heart diseases	0.000	0.998	0.001
I00-I02 Acute rheumatic fever	0.000	0.998	0.001
E03.8 Other specified hypothyroidism	0.000	0.999	0.001
E03.5 Myxoedema coma	0.000	0.999	0.001
E03.4 Atrophy of thyroid (acquired)	0.000	0.999	0.001
E03.3 Postinfectious hypothyroidism	0.000	0.999	0.001
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.999	0.001
E03.1 Congenital hypothyroidism without goitre	0.000	0.999	0.001
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.999	0.001
E14.8 With unspecified complications	0.000	0.999	0.001
E14.7 With multiple complications	0.000	0.999	0.001
E14.6 With other specified complications	0.000	0.999	0.001
E14.5 With peripheral circulatory complications	0.000	0.999	0.001
E14.4 With neurological complications	0.000	0.999	0.001
E14.3 With ophthalmic complications	0.000	0.999	0.001
E14.2 Withrenal complications	0.000	0.999	0.001
E14.1 With ketoacidosis	0.000	0.999	0.001
E14.0 With coma	0.000	0.999	0.001
I11.9 Hypertensive heart disease without (congestive) heart failure	0.000	0.999	0.001
I11.0 Hypertensive heart disease with (congestive) heart failure	0.000	0.999	0.001
I12.9 Hypertensive renal disease without renal failure	0.000	0.999	0.001
I12.0 Hypertensive renal disease with renal failure	0.000	0.999	0.001
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.999	0.001
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.999	0.001
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.999	0.001
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.999	0.001
I15.9 Seconday hypertension, unspecified	0.000	0.999	0.001
I15.8 Other secondary hypertension	0.000	0.999	0.001
I15.2 Hypertension secondary to endocrine disorders	0.000	0.999	0.001
I15.1 Hypertension secondary to other renal disorders	0.000	0.999	0.001
I15.0 Renovascular hypertension	0.000	0.999	0.001
I95-I99 Other and unspecified disorders of the circulatory system	0.000	0.999	0.001
I30-I52 Other forms of heart disease	0.000	0.999	0.001
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.000	0.999	0.001
I60-I69 Cerebrovascular diseases	0.000	0.999	0.001
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.999	0.001
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.999	0.001
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.999	0.001
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.999	0.001
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.999	0.001
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.999	0.001
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.999	0.001
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.999	0.001
E04.9 Non-toxic goitre, unspecified	0.000	0.999	0.001
E04.8 Other specified non-toxic goitre	0.000	0.999	0.001
E04.2 Non-toxic multinodular goitre	0.000	0.999	0.001
E04.1 Non-toxic single thyroid nodule	0.000	0.999	0.001
E04.0 Non-toxic diffuse goitre	0.000	0.999	0.001
E05.9 Thyrotoxicosis, unspecified	0.000	0.999	0.001
E05.8 Other thyrotoxicosis	0.000	0.999	0.001
E05.5 Thyroid crisis or storm	0.000	0.999	0.001
E05.4 Thyrotoxicosis factitia	0.000	0.999	0.001
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.999	0.001
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.999	0.001
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.999	0.001
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.999	0.001
E06.9 Thyroiditis, unspecified	0.000	0.999	0.001
E06.5 Other chronic thyroiditis	0.000	0.999	0.001
E06.4 Drug-induced thyroiditis	0.000	0.999	0.001
E06.3 Autoimmune thyroiditis	0.000	0.999	0.001
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.999	0.001
E06.1 Subacute thyroiditis	0.000	0.999	0.001
E06.0 Acute thyroiditis	0.000	0.999	0.001
E07.9 Disorder of thyroid, unspecified	0.000	0.999	0.001
E07.8 Other specified disorders of thyroid	0.000	0.999	0.001
E07.1 Dyshormogenetic goitre	0.000	0.999	0.001
E07.0 Hypersecretion of calcitonin	0.000	0.999	0.001
N81.6 Rectocele	0.000	0.999	0.001
E67 Other hyperalimentation	0.000	0.999	0.001
E68 Sequelae of hyperalimentation	0.000	0.999	0.001
E65 Localised adiposity	0.000	0.999	0.001
E14.9 Without complications	0.000	0.999	0.001
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.999	0.001
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.999	0.001
E16.4 Abnormal secretion of gastrin	0.000	0.999	0.001
E16.3 Increased secretion of glucagon	0.000	0.999	0.001
E16.2 Hypoglycaemia, unspecified	0.000	0.999	0.001
E16.1 Other hypoglycaemia	0.000	0.999	0.001
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.999	0.001
E20.9 Hypoparathyroidism, unspecified	0.000	0.999	0.001
E20.8 Other hypoparathyroidism	0.000	0.999	0.001
E20.1 Pseudohypoparathyroidism	0.000	0.999	0.001
E20.0 Idiopathic hypoparathyroidism	0.000	0.999	0.001
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.999	0.001
E21.4 Other specified disorders of parathyroid gland	0.000	0.999	0.001
E21.3 Hyperparathyroidism, unspecified	0.000	0.999	0.001
E21.2 Other hyperparathyroidism	0.000	0.999	0.001
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.999	0.001
E21.0 Primary hyperparathyroidism	0.000	0.999	0.001
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.999	0.001
E22.8 Other hyperfunction of pituitary gland	0.000	0.999	0.001
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.999	0.001
E22.1 Hyperprolactinaemia	0.000	0.999	0.001
E22.0 Acromegaly and pituitary gigantism	0.000	0.999	0.001
E23.7 Disorder of pituitary gland, unspecified	0.000	0.999	0.001
E23.6 Other disorders of pituitary gland	0.000	0.999	0.001
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.999	0.001
E23.2 Diabetes insipidus	0.000	0.999	0.001
E23.1 Drug-induced hypopituitarism	0.000	0.999	0.001
E23.0 Hypopituitarism	0.000	0.999	0.001
E24.9 Cushing's syndrome, unspecified	0.000	0.999	0.001
E24.8 Other Cushing's syndrome	0.000	0.999	0.001
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.999	0.001
E24.3 Ectopic ACTH syndrome	0.000	0.999	0.001
E24.2 Drug-induced Cushing's syndrome	0.000	0.999	0.001
E24.1 Nelson's syndrome	0.000	0.999	0.001
E24.0 Pituitary-dependent Cushing's disease	0.000	0.999	0.001
E25.9 Adrenogenital disorder, unspecified	0.000	0.999	0.001
E25.8 Other adrenogenital disorders	0.000	0.999	0.001
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.999	0.001
E26.9 Hyperaldosteronism, unspecified	0.000	0.999	0.001
E26.8 Other hyperaldosteronism	0.000	0.999	0.001
E26.1 Secondary hyperaldosteronism	0.000	0.999	0.001
E26.0 Primary hyperaldosteronism	0.000	0.999	0.001
E27.9 Disorder of adrenal gland, unspecified	0.000	0.999	0.001
E27.8 Other specified disorders of adrenal gland	0.000	0.999	0.001
E27.5 Adrenomedullary hyperfunction	0.000	0.999	0.001
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.999	0.001
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.999	0.001
E27.2 Addisonian crisis	0.000	0.999	0.001
E27.1 Primary adrenocortical insufficiency	0.000	0.999	0.001
E27.0 Other adrenocortical overactivity	0.000	0.999	0.001
E28.9 Ovarian dysfunction, unspecified	0.000	0.999	0.001
E28.8 Other ovarian dysfunction	0.000	0.999	0.001
E28.3 Primary ovarian failure	0.000	0.999	0.001
E28.2 Polycystic ovarian syndrome	0.000	0.999	0.001
E28.1 Androgen excess	0.000	0.999	0.001
E28.0 Oestrogen excess	0.000	0.999	0.001
E29.9 Testicular dysfunction, unspecified	0.000	0.999	0.001
E29.8 Other testicular dysfunction	0.000	0.999	0.001
E29.1 Testicular hypofunction	0.000	0.999	0.001
E29.0 Testicular hyperfunction	0.000	0.999	0.001
E30.9 Disorder of puberty, unspecified	0.000	0.999	0.001
E30.8 Other disorders of puberty	0.000	0.999	0.001
E30.1 Precocious puberty	0.000	0.999	0.001
E30.0 Delayed puberty	0.000	0.999	0.001
E31.9 Polyglandular dysfunction, unspecified	0.000	0.999	0.001
E31.8 Other polyglandular dysfunction	0.000	0.999	0.001
E31.1 Polyglandular hyperfunction	0.000	0.999	0.001
E31.0 Autoimmune polyglandular failure	0.000	0.999	0.001
E32.9 Disease of thymus, unspecified	0.000	0.999	0.001
E32.8 Other diseases of thymus	0.000	0.999	0.001
E32.1 Abscess of thymus	0.000	0.999	0.001
E32.0 Persistent hyperplasia of thymus	0.000	0.999	0.001
E34.9 Endocrine disorder, unspecified	0.000	0.999	0.001
E34.8 Other specified endocrine disorders	0.000	0.999	0.001
E34.5 Androgen resistance syndrome	0.000	0.999	0.001
E34.4 Constitutional tall stature	0.000	0.999	0.001
E34.3 Short stature, not elsewhere classified	0.000	0.999	0.001
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.999	0.001
E34.1 Other hypersecretion of intestinal hormones	0.000	0.999	0.001
E34.0 Carcinoid syndrome	0.000	0.999	0.001
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.999	0.001
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.999	0.001
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.999	0.001
E44.1 Mild protein-energy malnutrition	0.000	0.999	0.001
E44.0 Moderate protein-energy malnutrition	0.000	0.999	0.001
E50.9 Vitamin A deficiency, unspecified	0.000	0.999	0.001
E50.8 Other manifestations of vitamin A deficiency	0.000	0.999	0.001
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.999	0.001
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.999	0.001
E50.5 Vitamin A deficiency with night blindness	0.000	0.999	0.001
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.999	0.001
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.999	0.001
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.999	0.001
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.999	0.001
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.999	0.001
E51.9 Thiamine deficiency, unspecified	0.000	0.999	0.001
E51.8 Other manifestations of thiamine deficiency	0.000	0.999	0.001
E51.2 Wernicke's encephalopathy	0.000	0.999	0.001
E51.1 Beriberi	0.000	0.999	0.001
E53.9 Vitamin B deficiency, unspecified	0.000	0.999	0.001
E53.8 Deficiency of other specified B group vitamins	0.000	0.999	0.001
E53.1 Pyridoxine deficiency	0.000	0.999	0.001
E53.0 Riboflavin deficiency	0.000	0.999	0.001
E55.9 Vitamin D deficiency, unspecified	0.000	0.999	0.001
E55.0 Rickets, active	0.000	0.999	0.001
E56.9 Vitamin deficiency, unspecified	0.000	0.999	0.001
E56.8 Deficiency of other vitamins	0.000	0.999	0.001
E56.1 Deficiency of vitamin K	0.000	0.999	0.001
E56.0 Deficiency of vitamin E	0.000	0.999	0.001
E61.9 Deficiency of nutrient element, unspecified	0.000	0.999	0.001
E61.8 Deficiency of other specified nutrient elements	0.000	0.999	0.001
E61.7 Deficiency of multiple nutrient elements	0.000	0.999	0.001
E61.6 Vanadium deficiency	0.000	0.999	0.001
E61.5 Molybdenum deficiency	0.000	0.999	0.001
E61.4 Chromium deficiency	0.000	0.999	0.001
E61.3 Manganese deficiency	0.000	0.999	0.001
E61.2 Magnesium deficiency	0.000	0.999	0.001
E61.1 Iron deficiency	0.000	0.999	0.001
E61.0 Copper deficiency	0.000	0.999	0.001
E63.9 Nutritional deficiency, unspecified	0.000	0.999	0.001
E63.8 Other specified nutritional deficiencies	0.000	0.999	0.001
E63.1 Imbalance of constituents of food intake	0.000	0.999	0.001
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.999	0.001
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.999	0.001
E64.8 Sequelae of other nutritional deficiencies	0.000	0.999	0.001
E64.3 Sequelae of rickets	0.000	0.999	0.001
E64.2 Sequelae of vitamin C deficiency	0.000	0.999	0.001
E64.1 Sequelae of vitamin A deficiency	0.000	0.999	0.001
E64.0 Sequelae of protein-energy malnutrition	0.000	0.999	0.001
Z86.5 Personal history of other mental and behavioural disorders	0.000	0.999	0.001
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.000	0.999	0.001
Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.999	0.001
N81.1 Cystocele	0.000	0.999	0.001
I02 Rheumatic chorea	0.000	0.999	0.001
I01 Rheumatic fever with heart involvement	0.000	0.999	0.001
I00 Rheumatic fever without mention of heart involvement	0.000	0.999	0.001
I09 Other rheumatic heart diseases	0.000	0.999	0.001
I08 Multiple valve diseases	0.000	0.999	0.001
I07 Rheumatic tricuspid valve diseases	0.000	0.999	0.001
I06 Rheumatic aortic valve diseases	0.000	0.999	0.001
I05 Rheumatic mitral valve diseases	0.000	0.999	0.001
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations